• CLSI M23-Ed4

CLSI M23-Ed4

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; 4th Edition M23Ed4E

Clinical and Laboratory Standards Institute , 01/01/2016

Publisher: CLSI

File Format: PDF

$90.00$180.00


Clinical and Laboratory Standards Institute document M23–Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters offers guidance for developing interpretive criteria and QC ranges for antimicrobial susceptibility tests against aerobic and anaerobic bacteria, and selected fungi performed by CLSI antimicrobial susceptibility testing standards. It describes the data used by the Subcommittees on Antimicrobial Susceptibility Testing and Antifungal Susceptibility Tests to establish these interpretive criteria and QC ranges for antimicrobial agents, including microbiological data, pharmacokinetic and pharmacodynamic characteristics, and clinical data. As antimicrobial agents are used in practice, additional experience accrued may be used to reassess interpretive criteria or QC ranges. Users of these guidelines should understand that susceptibility test results cannot predict clinical outcomes with absolute certainty. They should be used along with the best clinical judgment and laboratory support to draw the best conclusions to serve the patient.

CLSI M23-Ed4 History

CLSI M23-Ed5

CLSI M23-Ed5

$90.00 $180.00

CLSI M23-Ed4

CLSI M23-Ed4

$90.00 $180.00

CLSI M23-A3

CLSI M23-A3

$134.00 $269.62

CLSI M23A2

CLSI M23A2

$121.00 $242.68

More CLSI Standards PDF

CSA C22.2 NO. 331-17 (R2021)
CSA Z245.12-17

CSA Z245.12-17

$100.00 $200.00

CSA Z245.15-17

CSA Z245.15-17

$117.00 $235.00

CSA ANSI Z21.10.1-2017/CSA 4.1-2017